Contract W81K0224F0139
The Republic Of Korea National Red Cross · Department Of Defense · September 19, 2024
The Republic Of Korea National Red Cross was awarded a federal contract by Department Of Defense (Department Of The Army) on September 19, 2024 for $9,000 (current value) of work in in-vitro diagnostic substance manufacturing. This is a task or delivery order issued under parent IDIQ W81K0222A0009. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $9,000.
Contract details
- PIID
- W81K0224F0139
- Parent IDIQ
- W81K0222A0009
- Award type
- Bpa Call
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- First action
- September 19, 2024
Description
AHPERESIS PLATELETS(A-PLT) 250ML
Modification timeline
-
September 19, 2024Base award$9.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0224F0139?
Contract W81K0224F0139 is a federal contract awarded to The Republic Of Korea National Red Cross by Department Of Defense on September 19, 2024 for $9,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract W81K0224F0139?
The Republic Of Korea National Red Cross won contract W81K0224F0139 from Department Of Defense.
How much is contract W81K0224F0139 worth?
Contract W81K0224F0139 has obligated $0 to date but carries a potential ceiling of $9,000 if fully funded and all options are exercised.